Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival.

ISRN surgery Pub Date : 2013-08-29 eCollection Date: 2013-01-01 DOI:10.1155/2013/175304
Apichat Tantraworasin, Somcharoen Saeteng, Nirush Lertprasertsuke, Nuttapon Arayawudhikule, Choosak Kasemsarn, Jayanton Patumanond
{"title":"Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival.","authors":"Apichat Tantraworasin,&nbsp;Somcharoen Saeteng,&nbsp;Nirush Lertprasertsuke,&nbsp;Nuttapon Arayawudhikule,&nbsp;Choosak Kasemsarn,&nbsp;Jayanton Patumanond","doi":"10.1155/2013/175304","DOIUrl":null,"url":null,"abstract":"<p><p>Background. Although early stage non-small cell lung cancer (NSCLC) has an excellent outcome and correlated with good long-term survival, up to 15 percent of patients still relapse postoperatively and die. This study is conducted to identify prognostic factors that may affect the long-term survival in completely resected N0 NSCLC. Methods. Medical records of 124 patients with completely resected N0 NSCLC were retrospectively reviewed. Prognostic factors affecting long-term survival were analyzed by the Kaplan-Meier method and Cox proportional hazards analysis. Results. Overall five-year survival rate was 48 percent. Multivariable analysis revealed stage of disease, tumor necrosis, tumor recurrence, brain metastasis, adrenal metastases, and skin metastases as significant prognostic factors affecting long-term survival. The hazard ratio (HR) of tumor necrosis, tumor recurrence, brain metastasis, adrenal metastases, and skin metastases was 2.0, 2.3, 7.6, 4.1, and 8.3, respectively, and all P values were less than 0.001. Conclusions. Our study shows stage of disease, tumor necrosis, tumor recurrence, brain metastasis, adrenal metastasis, and skin metastasis as the independent prognostic factors of long-term survival in pathological N0 NSCLC. Early stage NSCLC patients without nodal involvement or presented with tumor necrosis should benefit from adjuvant chemotherapy, and sites of metastasis could predict the long-term survival as described. </p>","PeriodicalId":89400,"journal":{"name":"ISRN surgery","volume":"2013 ","pages":"175304"},"PeriodicalIF":0.0000,"publicationDate":"2013-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/175304","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2013/175304","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

Abstract

Background. Although early stage non-small cell lung cancer (NSCLC) has an excellent outcome and correlated with good long-term survival, up to 15 percent of patients still relapse postoperatively and die. This study is conducted to identify prognostic factors that may affect the long-term survival in completely resected N0 NSCLC. Methods. Medical records of 124 patients with completely resected N0 NSCLC were retrospectively reviewed. Prognostic factors affecting long-term survival were analyzed by the Kaplan-Meier method and Cox proportional hazards analysis. Results. Overall five-year survival rate was 48 percent. Multivariable analysis revealed stage of disease, tumor necrosis, tumor recurrence, brain metastasis, adrenal metastases, and skin metastases as significant prognostic factors affecting long-term survival. The hazard ratio (HR) of tumor necrosis, tumor recurrence, brain metastasis, adrenal metastases, and skin metastases was 2.0, 2.3, 7.6, 4.1, and 8.3, respectively, and all P values were less than 0.001. Conclusions. Our study shows stage of disease, tumor necrosis, tumor recurrence, brain metastasis, adrenal metastasis, and skin metastasis as the independent prognostic factors of long-term survival in pathological N0 NSCLC. Early stage NSCLC patients without nodal involvement or presented with tumor necrosis should benefit from adjuvant chemotherapy, and sites of metastasis could predict the long-term survival as described.

Abstract Image

Abstract Image

Abstract Image

完全切除非小细胞肺癌:影响长期生存的预后因素。
背景。尽管早期非小细胞肺癌(NSCLC)具有良好的预后和良好的长期生存率,但高达15%的患者仍然术后复发并死亡。本研究旨在确定可能影响完全切除的N0型NSCLC患者长期生存的预后因素。方法。回顾性分析124例完全切除的N0型NSCLC患者的病历。采用Kaplan-Meier法和Cox比例风险分析分析影响长期生存的预后因素。结果。总体5年生存率为48%。多变量分析显示,疾病分期、肿瘤坏死、肿瘤复发、脑转移、肾上腺转移和皮肤转移是影响长期生存的重要预后因素。肿瘤坏死、肿瘤复发、脑转移、肾上腺转移和皮肤转移的风险比(HR)分别为2.0、2.3、7.6、4.1和8.3,P值均小于0.001。结论。我们的研究表明,疾病分期、肿瘤坏死、肿瘤复发、脑转移、肾上腺转移和皮肤转移是病理性N0 NSCLC长期生存的独立预后因素。无淋巴结累及或肿瘤坏死的早期NSCLC患者应该从辅助化疗中获益,转移部位可以预测长期生存。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信